Search and analyze individual stocks with comprehensive metrics

Entero Healthcare Solutions Limited

ENTERORetailing

Fundamental Score

...

Entero Healthcare Solutions Limited Share Price & Market Analysis

Current Market Price (CMP)
1108.80
No change data available
Market Cap
4.75K (Cr)
Industry
Retailing

Profitability Metrics

Poor

Return on Equity

5.63%
Poor

Return on Capital Employed

8.71%
Poor

Operating Profit Margin (5Y)

2.33%
Poor

Dividend Yield

0.00%

Valuation Metrics

Average

Price to Earnings

46.28x

Market Capitalization

4.75K (Cr)

Industry P/E

49.69x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

38.45%
Excellent

YoY Quarterly Sales Growth

27.96%
Excellent

Sales Growth (5Y)

30.44%
Poor

EPS Growth (5Y)

-25.34%
Excellent

Profit Growth (5Y)

151.54%

Financial Health

Excellent

Debt to Equity

0.22x
Excellent

Interest Coverage

4.47x
Poor

Free Cash Flow (5Y)

-302.73 (Cr)

Ownership Structure

Good

Promoter Holding

52.42%
Good

FII Holding

17.21%
Good

DII Holding

10.19%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
52.42%
Promoter Holding
4.75K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ENTERO across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Robust Profit Growth (38.45%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (27.96%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (30.44% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (151.54% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Conservative Debt Levels (D/E: 0.22)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Balanced Promoter Holding (52.42%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Strong Institutional Confidence (FII+DII: 27.40%)

Observation: Significant professional investor participation indicates quality recognition.

Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

8 factors identified

Below-Average Return on Equity (5.63%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (8.71%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Margin Pressure Concerns (2.33%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Premium Valuation Risk (P/E: 46.28x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Weak Earnings Growth (-25.34% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Negative Free Cash Flow (₹-302.73 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmacy Retail sector...

Financial Statements

Comprehensive financial data for Entero Healthcare Solutions Limited

About ENTERO

Company Details

Symbol:ENTERO
Industry:Retailing
Sector:Pharmacy Retail

Market Information

Market Cap:4.75K (Cr)
P/E Ratio:46.28
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

ENTERO Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)5.63%
Return on Capital Employed8.71%
Operating Profit Margin (5Y)2.33%
Debt to Equity Ratio0.22
Interest Coverage Ratio4.47

Growth & Valuation

Sales Growth (5Y)30.44%
Profit Growth (5Y)151.54%
EPS Growth (5Y)-25.34%
YoY Quarterly Profit Growth38.45%
YoY Quarterly Sales Growth27.96%

Frequently Asked Questions

What is the current price of ENTERO?

ENTERO is currently trading at ₹1108.80 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of ENTERO shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of ENTERO and what does it mean?

ENTERO has a P/E ratio of 46.28x compared to the industry average of 49.69x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹46 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is ENTERO performing according to Bull Run's analysis?

ENTERO has a Bull Run fundamental score of 57.9/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 5.63%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does ENTERO belong to?

ENTERO operates in the Retailing industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Entero Healthcare Solutions Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for ENTERO?

ENTERO has an ROE of 5.63%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Entero Healthcare Solutions Limited generates profits from shareholders' equity. An ROE of 6% means the company generates ₹6 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is ENTERO's debt-to-equity ratio and what does it indicate?

ENTERO has a debt-to-equity ratio of 0.22, which indicates conservative financing with low financial risk. This means the company has ₹22 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is ENTERO's dividend yield and is it a good dividend stock?

ENTERO offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has ENTERO grown over the past 5 years?

ENTERO has achieved 5-year growth rates of: Sales Growth 30.44%, Profit Growth 151.54%, and EPS Growth -25.34%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in ENTERO and why does it matter?

Promoters hold 52.42% of ENTERO shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does ENTERO compare with its industry peers?

ENTERO trades at P/E 46.28x vs industry average 49.69x, with ROE of 5.63% and ROCE of 8.71%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether ENTERO is outperforming its competitive set in profitability, growth, and valuation metrics.

What is ENTERO's market capitalization and what category does it fall into?

ENTERO has a market capitalization of ₹4746 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for ENTERO?

Key ratios for ENTERO: ROE 5.63% (Needs improvement), ROCE 8.71%, P/E 46.28x, Debt-to-Equity 0.22, Interest Coverage 4.47x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is ENTERO stock and what is its beta?

ENTERO has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for ENTERO?

ENTERO has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹1108.80, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in ENTERO?

Key risks for ENTERO include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.22), and operational challenges. The stock has a Fundamental Score of 57.9/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Retailing include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is ENTERO's operating profit margin and how has it trended?

ENTERO has a 5-year average Operating Profit Margin (OPM) of 2.33%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is ENTERO's quarterly performance in terms of sales and profit growth?

ENTERO's recent quarterly performance shows YoY Sales Growth of 27.96% and YoY Profit Growth of 38.45%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in ENTERO?

ENTERO has FII holding of 17.21% and DII holding of 10.19%, totaling 27.40% institutional ownership. This institutional participation level shows the confidence of professional money managers. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.